Some highlights from the news
Professor McDevitt said the next steps they were working towards were collecting the data required for a clinical trial of PBT2 in combination with antibiotics.
“We also want to find other antibiotic-PBT2 combinations that have therapeutic potential for treatment of other bacterial infections,” he said.“Our work shows that this simple combination therapy is safe, but the combinations require testing in clinical trials. What we need now is to move forward with further testing and pharmacology.”
New Clinical Trial for PBT2 may happen in the near future?
PBT2 News, page-2
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $203.0K | 45.14M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 104 | 103311567 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 31829254 | 17 |
View Market Depth
| Last trade - 10.53am 30/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |